Skip to main content
Exclusive Savings: Take 10% OFF All Cenmed Products | Upgrade Your Lab For Less Shop Now
US English

Aladdin Scientific

Cyclo(-RGDfK) TFA (C007B-102091)

InformationCyclo (-RGDfK) Cyclo (-RGDfK) is a potent and selective αvβ3 integrin inhibitor.Targetsαvβ3 integrinIn vitroThe constant of affinity (KD) of Cyclo (-RGDfK-) for purified integrin is 41.70 nM. Cyclo (-RGDfK) is reacting with HEK293(β3)

Description
InformationCyclo (-RGDfK) Cyclo (-RGDfK) is a potent and selective αvβ3 integrin inhibitor.Targetsαvβ3 integrinIn vitroThe constant of affinity (KD) of Cyclo (-RGDfK-) for purified integrin is 41.70 nM. Cyclo (-RGDfK) is reacting with HEK293(β3) cells moderately. Cyclo(-RGDfK-) modified micelles shows strong affinity to T-24 cells and strong inhibitory effect on the proliferation of T-24 cells.In vivoIn athymic mice bearing α(v)β(3)-integrin-positive C6 gliomas, Cyclo (-RGDfK-) modification induces less tumor progression, less tumor metabolic activity, fewer intratumoral vessels.Cell Research(from reference)Cell lines:T-24 cells Incubation Time:72 h. Specification: 0.99 Molecular Formula: C29H42F3N9O9 Molecular Weight: 717.69 PubChem CID: 91759592 Isomeric SMILES: C1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=CC=C2)CC(=O)O.C(=O)(C(F)(F)F)O Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/C413847-SCI_f3fd13650405a0032e065e6eae50b79c.pdf
Specifications
UPC:
51171809
Condition:
New
Weight:
0.96 Ounces
HazmatClass:
No
Quantity:
1
Unit of Measurement:
EA
WeightUOM:
LB
MPN:
C413847-5mg
CAS:
500577-51-5
Product Size:
5mg
Hazard Statement Codes:
H302:H315:H319:H335
Precautionary Statement Codes:
P261:P305+P351+P338
Catalog No. C007B-102091
Price: $192.05
List Price: $213.39
  • Guaranteed quality & reliable delivery
  • Shipping Lead-Time: 2 weeks
Adding to cart… The item has been added
Request a Quote

Enjoy exclusive benefits, including discounted pricing on bulk orders, by opening a Cenmed Business Account. Learn More.